Primary Site >> Colorectal Cancer
Gene >> EGFL7
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Deregulated expression of miR-106a predicts survival in human colon cancer patients. PMID: 18521848 |
Ref: Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer. PMID: 21737648 |
Ref: The expression of Egfl7 in human normal tissues and epithelial tumors. PMID: 23558933 Ref: Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. PMID: 23900443 |
Ref: Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis. PMID: 24815445 |
Ref: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study. PMID: 25592646 |
Ref: Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. PMID: 28539619 |
Ref: Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer. PMID: 29438092 Ref: Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. PMID: 29636300 Ref: EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis. PMID: 29923200 |